MedTrace Logo

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers

NCT02454387 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2016-06-30

No results posted yet for this study

Summary

A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in healthy volunteers.

Conditions

Interventions

DRUG

ONO-4474 Part A1

Healthy volunteers

DRUG

Placebo Part A1

Healthy volunteers

DRUG

ONO-4474 Part A2

Healthy volunteers

DRUG

Placebo Part A2

Healthy volunteers

DRUG

ONO-4474 Part B

Healthy volunteers

DRUG

Placebo Part B

Healthy volunteers

DRUG

ONO-4474 Part C

Healthy volunteers

DRUG

Placebo Part C

Healthy volunteers

DRUG

ONO-4474 Part D

Healthy volunteers

DRUG

Placebo Part D

Healthy volunteers

Sponsors & Collaborators

  • Ono Pharmaceutical Co. Ltd

    lead INDUSTRY

Principal Investigators

  • Drug Development Division · Ono Pharmaceutical Co. Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Denmark
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02454387 on ClinicalTrials.gov